All > Prostate Cancer

EMPOWER for Prostate Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Johns Hopkins University, Baltimore, MDProstate CancerEMPOWER - Behavioral
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

This trial will compare whether a weight-loss intervention can help prevent prostate cancer progression, compared to standard care.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
High-Dose-Rate Brachytherapy
1
CC-94676
1
PDT and verteporfin dose finding

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 6 months, 12 months, and 24 months

12 months
Proportion of men who develop prostate specific antigen (PSA) progression or radiographic progression
Month 24
Change in PSA
Change in diet
Change in physical activity
Change in waist circumference
Change in weight
Up to 24 months
PSA doubling time
Proportion of men who experience clinical progression

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
High-Dose-Rate Brachytherapy
1
CC-94676
1
PDT and verteporfin dose finding

Trial Design

2 Treatment Groups

Standard of Care
1 of 2
EMPOWER
1 of 2

Active Control

Experimental Treatment

130 Total Participants · 2 Treatment Groups

Primary Treatment: EMPOWER · No Placebo Group · N/A

EMPOWER
Behavioral
Experimental Group · 1 Intervention: EMPOWER · Intervention Types: Behavioral
Standard of CareNoIntervention Group · 1 Intervention: Standard of Care · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EMPOWER
2022
N/A
~40

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months, 12 months, and 24 months

Who is running the clinical trial?

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLead Sponsor
538 Previous Clinical Trials
31,064 Total Patients Enrolled
53 Trials studying Prostate Cancer
2,958 Patients Enrolled for Prostate Cancer
American Cancer Society, Inc.OTHER
213 Previous Clinical Trials
98,065 Total Patients Enrolled
11 Trials studying Prostate Cancer
1,541 Patients Enrolled for Prostate Cancer
Maryland Cigarette Restitution FundOTHER_GOV
4 Previous Clinical Trials
522 Total Patients Enrolled
2 Trials studying Prostate Cancer
421 Patients Enrolled for Prostate Cancer
Corinne Joshu, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health

Eligibility Criteria

Age 18+ · Male Participants · 14 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a body mass index (BMI) of 25 or higher.
You are willing to modify your diet, physical activity, and weight.
Men who have had surgery for their cancer cannot participate if they refuse or are not suitable for follow-up radiation treatment. Men who have cancer return within 3 years of receiving radiation treatment can participate.
References

Frequently Asked Questions

How many participants are admitted into this research experiment?

"Affirmative. According to clinicaltrials.gov, this medical investigation is open for recruitment. The experiment was announced on February 20th 2020 and the latest update occurred on March 18th 2022; 130 participants must be sourced from one location in total." - Anonymous Online Contributor

Unverified Answer

Is this research project open to new enrollees?

"This trial, which was initially published on February 20th 2020 and recently revised March 18th 2022, is currently seeking participants. Data hosted by clinicaltrials.gov confirms this fact." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top